REGENXBIO Inc.
DE ˙ DB ˙ US75901B1070
5,68 € ↑0,15 (2,68%)
2026-06-04
DEL PRIS
SecurityDE:RB0 / REGENXBIO Inc.
InstitutionInvesco Ltd.
Latest Disclosed Ownership158,829 shares
Latest Disclosed Value $ 1,330,987
Invesco Ltd. reports 0.59% increase in ownership of RB0 / REGENXBIO Inc.

On May 12, 2026 - Invesco Ltd. filed a 13F-HR form disclosing ownership of 158,829 shares of REGENXBIO Inc. (DE:RB0) valued at $1,095,920 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 19, 2026 disclosing 157,903 shares of REGENXBIO Inc.. This represents a change in shares of 0.59% during the quarter. The current value of the position is $901,831 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F REGENXBIO COM 75901B107 158,829 926 0.59 1,331 -41.49 0.0000
2026-02-19 2025-12-31 13F REGENXBIO COM 75901B107 157,903 8,023 5.35 2,274 57.19 0.0003
2025-11-13 2025-09-30 13F REGENXBIO COM 75901B107 149,880 36,671 32.39 1,446 55.65 0.0002
2025-08-13 2025-06-30 13F REGENXBIO COM 75901B107 113,209 33,740 42.46 929 63.56 0.0002
2025-05-12 2025-03-31 13F REGENXBIO COM 75901B107 79,469 27,341 52.45 568 41.29 0.0001
2025-02-13 2024-12-31 13F REGENXBIO COM 75901B107 52,128 -84,036 -61.72 403 -71.85 0.0001
2024-11-12 2024-09-30 13F REGENXBIO COM 75901B107 136,164 -13,248 -8.87 1,428 -18.31 0.0003
2024-08-13 2024-06-30 13F REGENXBIO COM 75901B107 149,412 7,368 5.19 1,748 -41.58 0.0004
2024-05-14 2024-03-31 13F REGENXBIO COM 75901B107 142,044 -4,176 -2.86 2,993 14.02 0.0006
2024-02-13 2023-12-31 13F REGENXBIO COM 75901B107 146,220 -87,027 -37.31 2,625 -31.65 0.0006
2023-11-13 2023-09-30 13F REGENXBIO COM 75901B107 233,247 -10,098 -4.15 3,839 -21.07 0.0010
2023-08-11 2023-06-30 13F REGENXBIO COM 75901B107 243,345 -359,492 -59.63 4,864 -57.33 0.0013
2023-05-12 2023-03-31 13F REGENXBIO COM 75901B107 602,837 -3,044 -0.50 11,400 -17.04 0.0032
2023-02-13 2022-12-31 13F REGENXBIO COM 75901B107 605,881 187,475 44.81 13,741 24.25 0.0040
2022-11-14 2022-09-30 13F REGENXBIO COM 75901B107 418,406 -99,514 -19.21 11,059 -13.55 0.0036
2022-08-15 2022-06-30 13F REGENXBIO COM 75901B107 517,920 297,903 135.40 12,792 75.16 0.0039
2022-05-16 2022-03-31 13F REGENXBIO COM 75901B107 220,017 10,482 5.00 7,303 6.60 0.0019
2022-02-14 2021-12-31 13F REGENXBIO COM 75901B107 209,535 -30,662 -12.77 6,851 -31.96 0.0017
2021-11-15 2021-09-30 13F REGENXBIO COM 75901B107 240,197 -223,403 -48.19 10,069 -44.09 0.0026
2021-08-17 2021-06-30 13F REGENXBIO COM 75901B107 463,600 235,216 102.99 18,010 131.19 0.0044
2021-05-17 2021-03-31 13F REGENXBIO COM 75901B107 228,384 46,285 25.42 7,790 -5.69 0.0021
2021-02-16 2020-12-31 13F REGENXBIO COM 75901B107 182,099 13,841 8.23 8,260 78.40 0.0024
2020-11-16 2020-09-30 13F REGENXBIO COM 75901B107 168,258 -13,464 -7.41 4,630 -30.82 0.0016
2020-08-14 2020-06-30 13F REGENXBIO COM 75901B107 181,722 -145,033 -44.39 6,693 -36.74 0.0024
2020-05-15 2020-03-31 13F REGENXBIO COM 75901B107 326,755 -143 -0.04 10,580 -21.00 0.0045
2020-02-14 2019-12-31 13F REGENXBIO COM 75901B107 326,898 7,691 2.41 13,393 17.85 0.0042
2019-11-14 2019-09-30 13F REGENXBIO COM 75901B107 319,207 -54,166 -14.51 11,364 -40.75 0.0030
2019-08-14 2019-06-30 13F/A-1 REGENXBIO COM 75901B107 373,373 -248,294 -39.94 19,181 -46.16 0.0049
2019-08-14 2019-06-30 13F REGENXBIO COM 75901B107 373,373 -488,387 19,181
2019-05-15 2019-03-31 13F REGENXBIO COM 75901B107 621,667 305 0.05 35,628 36.68 0.0120
2019-02-14 2018-12-31 13F REGENXBIO COM 75901B107 621,362 -131,251 -17.44 26,066 -54.13 0.0100
2018-11-14 2018-09-30 13F REGENXBIO COM 75901B107 752,613 117,236 18.45 56,822 24.64 0.0179
2018-08-14 2018-06-30 13F REGENXBIO COM 75901B107 635,377 343,265 117.51 45,588 422.80 0.0151
2018-05-15 2018-03-31 13F REGENXBIO COM 75901B107 292,112 -100,252 -25.55 8,720 -33.16 0.0033
2018-02-14 2017-12-31 13F REGENXBIO COM 75901B107 392,364 86,140 28.13 13,047 29.31 0.0047
2017-11-14 2017-09-30 13F REGENXBIO COM 75901B107 306,224 -99,805 -24.58 10,090 25.81 0.0037
2017-08-14 2017-06-30 13F REGENXBIO COM 75901B107 406,029 -9,248 -2.23 8,020 0.05 0.0025
2017-05-15 2017-03-31 13F REGENXBIO COM 75901B107 415,277 54,532 15.12 8,016 19.78 0.0026
2017-02-14 2016-12-31 13F REGENXBIO COM 75901B107 360,745 60,350 20.09 6,692 58.99 0.0022
2016-11-14 2016-09-30 13F REGENXBIO COM 75901B107 300,395 -57 -0.02 4,209 75.08 0.0014
2016-08-15 2016-06-30 13F REGENXBIO COM 75901B107 300,452 252 0.08 2,404 -25.85 0.0009
2016-05-16 2016-03-31 13F REGENXBIO COM 75901B107 300,200 0 0.00 3,242 -34.94 0.0013
2016-02-16 2015-12-31 13F REGENXBIO COM 75901B107 300,200 200 0.07 4,983 -24.60 0.0020
2015-11-16 2015-09-30 13F REGENXBIO COM 75901B107 300,000 300,000 6,609 0.0028
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.